This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Guideline

. 2001 Aug;12(8):1059-60.

doi: 10.1023/a:1017413507554.

ESMO Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)

ESMO.

PMID: 11583185
DOI: 10.1023/a:1017413507554

Free article

Guideline

ESMO Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV)

ESMO.. Ann Oncol. 2001 Aug.

Free article

. 2001 Aug;12(8):1059-60.

doi: 10.1023/a:1017413507554.

Author

ESMO.

PMID: 11583185
DOI: 10.1023/a:1017413507554

No abstract available

PubMed Disclaimer

Similar articles

Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis.
Herrstedt J, Roila F; ESMO Guidelines Working Group. Herrstedt J, et al. Ann Oncol. 2008 May;19 Suppl 2:ii110-2. doi: 10.1093/annonc/mdn105. Ann Oncol. 2008. PMID: 18456745 No abstract available.
ESMO Minimum Clinical Recommendations for prophylaxis of chemotherapy-induced nausea and vomiting (NV).
Herrstedt J, Aapro MS, Roila F, Kataja VV; ESMO Guidelines Task Force. Herrstedt J, et al. Ann Oncol. 2005;16 Suppl 1:i77-9. doi: 10.1093/annonc/mdi805. Ann Oncol. 2005. PMID: 15888767 No abstract available.
Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis.
Herrstedt J, Roila F; ESMO Guidelines Working Group. Herrstedt J, et al. Ann Oncol. 2009 May;20 Suppl 4:156-8. doi: 10.1093/annonc/mdp160. Ann Oncol. 2009. PMID: 19454442 Review. No abstract available.
Chemotherapy-induced nausea and vomiting: ESMO clinical recommendations for prophylaxis.
ESMO Guidelines Working Group; Herrstedt J. ESMO Guidelines Working Group, et al. Ann Oncol. 2007 Apr;18 Suppl 2:ii83-5. doi: 10.1093/annonc/mdm050. Ann Oncol. 2007. PMID: 17491061 No abstract available.
[Prophylaxis of chemotherapy-induced vomiting and nausea].
Tóth J, Szántó J. Tóth J, et al. Magy Onkol. 2008 Dec;52(4):391-4. doi: 10.1556/MOnkol.52.2008.4.9. Magy Onkol. 2008. PMID: 19068468 Review. Hungarian.

See all similar articles

Cited by

Delayed emesis: moderately emetogenic chemotherapy.
Roila F, Warr D, Clark-Snow RA, Tonato M, Gralla RJ, Einhorn LH, Herrstedt J. Roila F, et al. Support Care Cancer. 2005 Feb;13(2):104-8. doi: 10.1007/s00520-004-0700-8. Epub 2004 Nov 12. Support Care Cancer. 2005. PMID: 15549426 Review.
Antiemetic prescription in Italian breast cancer patients submitted to adjuvant chemotherapy.
Drug Utilization Review Team in Oncology (DURTO). Drug Utilization Review Team in Oncology (DURTO). Support Care Cancer. 2003 Dec;11(12):785-9. doi: 10.1007/s00520-003-0478-0. Epub 2003 Oct 25. Support Care Cancer. 2003. PMID: 14579136
The role of electrogastrography and gastrointestinal hormones in chemotherapy-related dyspeptic symptoms.
Riezzo G, Clemente C, Leo S, Russo F. Riezzo G, et al. J Gastroenterol. 2005 Dec;40(12):1107-15. doi: 10.1007/s00535-005-1708-7. J Gastroenterol. 2005. PMID: 16378174
Acute emesis: moderately emetogenic chemotherapy.
Herrstedt J, Koeller JM, Roila F, Hesketh PJ, Warr D, Rittenberg C, Dicato M. Herrstedt J, et al. Support Care Cancer. 2005 Feb;13(2):97-103. doi: 10.1007/s00520-004-0701-7. Epub 2004 Nov 23. Support Care Cancer. 2005. PMID: 15565276 Review.
Aprepitant: a review of its use in the prevention of chemotherapy-induced nausea and vomiting.
Dando TM, Perry CM. Dando TM, et al. Drugs. 2004;64(7):777-94. doi: 10.2165/00003495-200464070-00013. Drugs. 2004. PMID: 15025555 Review.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information